Elongation inhibitors

The latter type of compounds should preferably carry either one type I unit or at most two units (positioned as far apart as possible), and have an elongated structure (which does not fold as verapamil, for example) with a small cross-sectional area, Ad- The first type of compounds is expected to be transported slowly, whereas the second type may not be transported. Table 20.2 summarizes the drug properties relevant for transporter binding and lipid partitioning of a substrate (modulator or inhibitor) of P-gp. Inspection of the information contained in Table 20.2 shows that the synthesis and membrane incorporation of inhibitors with a low number of H-bond acceptor patterns should be simpler and more efficient than that of inhibitors with a large number of patterns. 

The test aimed at determining whether the target of a translational inhibitor is tRNA aminoacylation requires four precharged aa-tRNAs (f Met-tRNA, Thr-tRNA, Ile-tRNA, and [14C] Phe-tRNA). Here, we present the protocol for the aminoacylation of the elongator tRNAs, while fMet-tRNA preparation is described in detail in the accompanying chapter by Milon et al, (2007). 

The application of forward chemical genetics to studies of translation provides an opportunity to identify small molecules that inhibit or stimulate this process without any underlying assumptions as to which step is most amenable to targeting by the chemical libraries under consideration. The opportunity exists to identify novel factors involved in translation, unravel new activities of known translation initiation factors, or characterize shortlived intermediates that are frozen by the small molecule inhibitor. We have undertaken a forward chemical genetic approach to identify small molecules that inhibit or stimulate translation in extracts prepared from Krebs-2 ascites cells (Novae et al., 2004). These screens have led to the identification of several novel inhibitors of translation initiation and elongation (Bordeleau et al., 2005, 2006 Robert et al., 2006a,b). 

Our screen has the potential to identify inhibitors of cap-dependent initiation, IRES-mediated initiation, and translation elongation or termination. One assay to identify initiation inhibitors from hits obtained in the primary screen is to assess the ability of a given compound to prevent 48S and/or 80S initiation complex formation on a capped mRNA and on the HCV IBJ3S. Because initiation complexes are formed more efficiently in RRL than in... 

Scheme 6.23 Synthesis of plasmepsin I and II inhibitors with elongated Pl/PT side chains.

Under the conditions where the chain oxidation process occurs, this reaction results in chain termination. In the presence of ROOH with which the ions react to form radicals, this reaction is disguised. However, in the systems where hydroperoxide is absent and the initiating function of the catalyst is not manifested, the latter has a retarding effect on the process. It was often observed that the introduction of cobalt, manganese, or copper salts into the initial hydrocarbon did not accelerate the process but on the contrary, resulted in the induction period and elongated it [4-6]. The induction period is caused by chain termination in the reaction of R02 with Mn"+, and cessation of retardation is due to the formation of ROOH, which interacts with the catalyst and thus transforms it from the inhibitor into the component of the initiating system. 

---